116 related articles for article (PubMed ID: 23648396)
1. An industry statistician's perspective on PHC drug development.
Fridlyand J; Yeh RF; Mackey H; Bengtsson T; Delmar P; Spaniolo G; Lieberman G
Contemp Clin Trials; 2013 Nov; 36(2):624-35. PubMed ID: 23648396
[TBL] [Abstract][Full Text] [Related]
2. A statistician's perspective on biomarkers in drug development.
Jenkins M; Flynn A; Smart T; Harbron C; Sabin T; Ratnayake J; Delmar P; Herath A; Jarvis P; Matcham J;
Pharm Stat; 2011; 10(6):494-507. PubMed ID: 22162336
[TBL] [Abstract][Full Text] [Related]
3. New paradigm for drug developments--from emerging market statistical perspective.
Quan H; Chen X; Zhang J; Zhao PL
Contemp Clin Trials; 2013 Nov; 36(2):697-703. PubMed ID: 23810938
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Challenges of biomarkers in drug discovery and development.
Goodsaid F
Expert Opin Drug Discov; 2012 Jun; 7(6):457-61. PubMed ID: 22471322
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
[TBL] [Abstract][Full Text] [Related]
7. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
8. Sample size and threshold estimation for clinical trials with predictive biomarkers.
Mackey HM; Bengtsson T
Contemp Clin Trials; 2013 Nov; 36(2):664-72. PubMed ID: 24064355
[TBL] [Abstract][Full Text] [Related]
9. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
10. Economics of new oncology drug development.
DiMasi JA; Grabowski HG
J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942
[TBL] [Abstract][Full Text] [Related]
11. Drug development in oncology: a regulatory perspective.
Augustus S
Am J Ther; 2011 Jul; 18(4):323-31. PubMed ID: 20335790
[TBL] [Abstract][Full Text] [Related]
12. When is a seamless study desirable? Case studies from different pharmaceutical sponsors.
Cuffe RL; Lawrence D; Stone A; Vandemeulebroecke M
Pharm Stat; 2014; 13(4):229-37. PubMed ID: 24891148
[TBL] [Abstract][Full Text] [Related]
13. Design issues in head and neck clinical trials: a statistician's perspective.
Fortpied C; Liberatoscioli C; Bogaerts J
Anticancer Drugs; 2011 Aug; 22(7):682-7. PubMed ID: 21709617
[TBL] [Abstract][Full Text] [Related]
14. Adaptive enrichment with subpopulation selection at interim: methodologies, applications and design considerations.
Wang SJ; Hung HM
Contemp Clin Trials; 2013 Nov; 36(2):673-81. PubMed ID: 24076485
[TBL] [Abstract][Full Text] [Related]
15. How to improve the clinical development paradigm and its division into phases I, II and III.
Bamberger M; Moore N; Lechat P;
Therapie; 2011; 66(4):331-4, 327-30. PubMed ID: 21851796
[TBL] [Abstract][Full Text] [Related]
16. Impact of biomarkers on clinical trial risk.
Reid GG; Bin Yameen TA; Parker JL
Pharmacogenomics; 2013 Oct; 14(13):1645-58. PubMed ID: 24088135
[TBL] [Abstract][Full Text] [Related]
17. Overcoming regulatory and economic challenges facing pharmacogenomics.
Cohen JP
N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials for predictive medicine.
Simon R
Stat Med; 2012 Nov; 31(25):3031-40. PubMed ID: 22714719
[TBL] [Abstract][Full Text] [Related]
19. Practical perspectives of personalized healthcare in oncology.
Hodgson DR; Wellings R; Harbron C
N Biotechnol; 2012 Sep; 29(6):656-64. PubMed ID: 22426411
[TBL] [Abstract][Full Text] [Related]
20. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
